Cancer is a complex disease with various components influenced by genomic changes that initiate tumor development and result in unpredictable growth patterns. Advances in high-throughput genomic technologies have transformed our understanding of cancer biology, enabling the identification of key mutations that drive tumor growth amidst the intricate variations within tumors. This chapter highlights the crucial role of genomics in tailoring cancer treatments to individual patients. It also provides a comprehensive overview of the range of somatic and germline alterations, including mutations, copy number variations, and structural rearrangements. The chapter emphasizes the functional significance of driver mutations in oncogenes and tumor suppressor genes, as well as their impact on targeted therapies. Emerging technologies like liquid biopsies, single-cell genomics, CRISPR-based genome editing, and next-generation sequencing are discussed as groundbreaking tools for advancing personalized medicine and cancer treatment. The convergence of multi-omics approaches, integrating genomics with transcriptomics, proteomics, and metabolomics, is also explored. This integration uncovers the intricate complexity of cancer, leading to the identification of more effective strategies and goals for combating tumors. This chapter further addresses the role of the tumor microenvironment and genomic interactions in shaping immune responses and in developing biomarkers for immunotherapy. Despite the breakthroughs achieved in this field, challenges persist, including ethical and practical considerations in genomic testing, tumor heterogeneity, and the development of treatment resistance. Addressing these challenges, the chapter also explores future directions, such as the application of artificial intelligence, CRISPR-based functional genomics, and personalized cancer vaccines. Overall, this chapter underscores the central role of genomics in personalized cancer therapies, emphasizing the vital connection between basic research and clinical practice to improve treatment strategies.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Genomics and Key Alterations

  • A. Esmaeilzadeh,
  • F. Ebrahimi,
  • M. H. Makoui,
  • K. Hadiloo,
  • S. Taremi,
  • K. Esmaeilzadeh,
  • F. Afshari,
  • P. M. Yeganeh

摘要

Cancer is a complex disease with various components influenced by genomic changes that initiate tumor development and result in unpredictable growth patterns. Advances in high-throughput genomic technologies have transformed our understanding of cancer biology, enabling the identification of key mutations that drive tumor growth amidst the intricate variations within tumors. This chapter highlights the crucial role of genomics in tailoring cancer treatments to individual patients. It also provides a comprehensive overview of the range of somatic and germline alterations, including mutations, copy number variations, and structural rearrangements. The chapter emphasizes the functional significance of driver mutations in oncogenes and tumor suppressor genes, as well as their impact on targeted therapies. Emerging technologies like liquid biopsies, single-cell genomics, CRISPR-based genome editing, and next-generation sequencing are discussed as groundbreaking tools for advancing personalized medicine and cancer treatment. The convergence of multi-omics approaches, integrating genomics with transcriptomics, proteomics, and metabolomics, is also explored. This integration uncovers the intricate complexity of cancer, leading to the identification of more effective strategies and goals for combating tumors. This chapter further addresses the role of the tumor microenvironment and genomic interactions in shaping immune responses and in developing biomarkers for immunotherapy. Despite the breakthroughs achieved in this field, challenges persist, including ethical and practical considerations in genomic testing, tumor heterogeneity, and the development of treatment resistance. Addressing these challenges, the chapter also explores future directions, such as the application of artificial intelligence, CRISPR-based functional genomics, and personalized cancer vaccines. Overall, this chapter underscores the central role of genomics in personalized cancer therapies, emphasizing the vital connection between basic research and clinical practice to improve treatment strategies.